Par Drugs & Chemicals Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 21 | Jun' 20 | |
|---|---|---|
| Sales | 19.59 | 11.10 |
| Operating profit | 4.04 | 2.71 |
| Interest | 0.23 | 0.06 |
| Gross profit | 3.84 | 2.68 |
| EPS (Rs) | 1.80 | 2.61 |
Quarterly
results in details
| Sep' 21 | Jun' 20 | |
|---|---|---|
| Other income | 0.03 | 0.02 |
| Stock adjustment | -0.21 | -0.15 |
| Raw material | 7.02 | 4.50 |
| Power and fuel | - | - |
| Employee expenses | 0.96 | 0.81 |
| Excise | - | - |
| Admin and selling expenses | - | - |
| Research and development expenses | - | - |
| Expenses capitalised | - | - |
| Other expenses | 7.78 | 3.23 |
| Provisions made | - | - |
| Depreciation | 0.83 | 0.74 |
| Taxation | 0.79 | 0.34 |
| Net profit / loss | 2.22 | 1.61 |
| Extra ordinary item | - | - |
| Prior year adjustments | - | - |
| Equity capital | 12.30 | 6.15 |
| Equity dividend rate | - | - |
| Agg.of non-prom. shares (Lacs) | - | - |
| Agg.of non promotoholding (%) | - | - |
| OPM (%) | 20.64 | 24.45 |
| GPM (%) | 19.59 | 24.10 |
| NPM (%) | 11.32 | 14.43 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis